TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 2 | 1 | 2 | -8 | 3 | 5 | 19 | 3 | 3 | 4 |
| P | %wins | 0 | 50 | 50 | 50 | 50 | 50 | 42 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/20/18 19:02 | 9/18/18 | PRNB | Principia Biopharma Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sofinnova Venture Partners Viii, L.P. | CA | T | P.d | 4,590 | 17.00 | 0 | 270 | 15 | 2,038 | D | |||||||||||||||
10/13/15 13:26 | 10/13/15 | ACRS | Aclaris Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sofinnova Venture Partners Viii, L.P. | CA | T | P.d | 4,500 | 11.00 | 4 | 409 | 22 | 2,289 | D | 23 | -8 | 13 | 27 | 50 | 47 | 80 | ||||||||
10/6/15 16:09 | 10/6/15 | MIRN | Mirna Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sofinnova Venture Partners Viii, L.P. | CA | T | P.d | 6,000 | 7.00 | 3 | 857 | 40 | 2,975 | D | 0 | -8 | -8 | -18 | -13 | -41 | -74 | ||||||||
12/10/14 14:03 | 12/8/14 | HSGX | Histogenics Corp | DE | Health | Orthop | Orthopedic, Prosthetic & Surg | Sofinnova Venture Partners Viii, L.P. | CA | T | S.d | -11 | 11.00 | 0 | -1 | 0 | 2,077 | I | |||||||||||||||
12/10/14 14:03 | 12/8/14 | HSGX | Histogenics Corp | DE | Health | Orthop | Orthopedic, Prosthetic & Surg | Sofinnova Venture Partners Viii, L.P. | CA | T | P.d | 5,502 | 11.00 | 0 | 500 | 32 | 2,077 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |